D-Day
(9th October 2023)

Abstract Submission

The AAMLS 2023 Scientific Committee invites submission for oral / poster presentations on all aspects of Medical Laboratory Sciences that have not previously been published or presented.

To submit an abstract, please register for the Congress and login using your registered email address to upload your abstract under Abstract Submission section (My Page)

Or you can also download the Abstract Submission Form and email the completed form together with your abstract to This email address is being protected from spambots. You need JavaScript enabled to view it..

Important Dates

Abstract Submission Deadline 31 July 2023 31 August 2023
Presenter’s Registration Deadline 31 August 2023
Presentation File Submission Deadline 8 September 2023

The presenting author must register for the congress. Accepted abstracts whose presenting author does not register and pay in full by the above deadline, will not be published in the final abstract book.

Abstract Preparation Guidelines

The AAMLS 2023 Scientific Committee invites submission for oral / poster presentations on all aspects of Medical Laboratory Sciences that have not previously been published or presented.

Language
Abstract must be written and presented in English.
Title
Title of abstract should not exceed 30 words. Do not use abbreviations in the title.
Name
The authors are to write their name as Given name, Surname/Family name (e.g. Yun Fatt, Chow; Aminah Ahmad; Bhavani Muthusamy; Francis Light). Do not include titles and degrees. Please bold the name of the presenter.
Institution
List the author’s institution by department, institution, city and country.
Abstract words
Abstract is to have 200-300 words.
Abstract body
Abstract is to have an introduction/aim, method, results, and conclusion.
Abbreviations
Define the abbreviation in the first use.
Data units
Data units must be in the International System of Units (SI units).
Keywords
Keywords must not be less than 3 words and not more than 5 words. Arrange the keywords in alphabetical order.
Font
Abstract to use font Times New Roman with a font size of 12 points.
Reproduce
Abstract reproduced will be as is submitted with no editing. The author is responsible for all spelling, grammatical or scientific errors.
Conflict of interest
The author must disclose conflict of interest to avoid any commercial bias.
Copyright
By submitting the abstract, the author grants the AAMLS 2023 the exclusive right to first publish the abstract and thereafter a non-exclusive right to publish, display and store the abstract in all forms, formats, and media. No fees shall be paid to the author by AAMLS 2023 for the license granted herein. The author will retain the copyright of his or her abstract as well.
Withdrawal
Authors who wish to withdraw their abstract must send a written request to the Scientific Committee at This email address is being protected from spambots. You need JavaScript enabled to view it.

Use the following excerpt as a format guide:

INVESTIGATION OF THE CHROMOSOME 6 INSTABILITY AND THE MAPK SIGNALING PATHWAYS IN HUMAN OSTEOSARCOMA

1 M. Rozi Ramli, 2 M.M. Hamdi, 3 Mohd Aminudin Mustapha 4 Mohamad Zulkarnaen Ahmad Narihan

1 Department of Pathology, Sarawak General Hospital (SGH), Jalan Hospital (SGH), Jalan Hospital, 93586 Kuching, Sarawak.

2 Department of Para-Clinical Science, Faculty of Medicine and Health Sciences (FMHS), UNIMAS, 94300 Kota Samarahan, Sarawak.

3 Pre-University Centre, UNIMAS,94300 Kota Samarahan, Sarawak.

4 Department of Pathology, FMHS, UNIMAS, 94300 Kota Samarahan, Sarawak.

*Presenter’s email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract
Osteosarcoma is the most common primary malignancy of bone with worldwide incidence of 2 to 3 million/year. This tumour usually develops at distal part of fast growing bone and associated with instability of chromosome 6. Despite that, the preceding molecular mechanism leading to the instability is not fully known. Following the local ethical committee review, from a total of 30 cases within 7years period (from October 2008 to October 2015). The study aimed to investigate the copy number of gene encoding vascular endothelial growth factor (VEGF) located at chromosome 6p21 using Fluorescence In Situ Hybridization (FISH) and the general chromosomal instability as indicated by micronuclei formation. In addition, VEGF, Hypoxia inducible factor (HIF) and p53 diagnostic immunohistochemistry (IHC) staining were performed as to investigate relationship of hypoxic stress and tumour growth suppress. Furthermore, the mitogen activated protein kinase (MAPK) cellular proliferation pathway molecules; ERK, p38 and JNK IHC were also examined. Our findings showed VEGF expression at both protein and gene level (6p21) indicating likelihood of neovascularization. On top of that, expressed ERK, p38 but not JNK; and expressed HIF & p53 in those cases suggest tumour cell survival by evading the natural cell death program, apoptosis. In conclusion, this study presented a possible molecular mechanism underlying chromosomal instability in human osteosarcoma.

Keywords: Osteosarcoma; mitogen activated protein kinase; chromosomal instability; 6p21

Abstract Review And Selection

Authors are encouraged to submit full paper and if selected by the Editorial Board, will be published as proceedings in the Malaysian Journal of Medical Laboratory Sciences (MJMLS).

The AAMLS 2023 Scientific Committee reserves the right to select papers relevant to the session. Presenters may present papers without having their papers published in congress proceedings or MJMLS.

AAMLS 2023 Secretariat

Malaysian Institute of Medical Laboratory Sciences (MIMLS)
1-5-14, Jalan Semarak Api (1/50),
Diamond Square Commercial Centre,
Off Jalan Gombak,
53000 Kuala Lumpur, MALAYSIA.

mymimls@mimls.org